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Significance for public health 
This study will be valuable as a reference in managing heart disease in pregnancy, particularly in 
a low middle-income country. Through understanding the detailed characteristics of heart disease 
in pregnant women, the clinicians, stakeholders, and policymakers can take the best approach to 
solve heart disease in their countries.   
 
Abstract 
Background: Heart disease in pregnancy is one of the leading causes of maternal mortality and 
morbidity in developing countries. However, the characteristics of the disease vary between 
countries and regions. This study aimed to present the characteristics of pregnant women with 
heart disease in an economically advantageous region of a developing country. 
Design and methods: A cross-sectional study was conducted using data from the Weekly Report 
of Obstetrics and Gynaecology Department to assess pregnant women with heart disease 
characteristics and pregnancy outcomes. A total sample of 69 pregnant women with heart disease 
regarding its gestational age was included in the study. Variables observed were maternal 
characteristics, heart disease's clinical parameter, and maternal and neonatal outcomes. Chi-square 
test was used to examine the different characteristics of congenital and acquired heart disease 
groups. 
Results: The prevalence of cardiac disease in pregnancy was 5.19%. Fifty-three point six percent 
of pregnant women with heart disease were suffered from congenital heart disease (CHD), while 
46.4% were acquired heart disease (AHD). Most labor methods were Cesarean delivery, and 
69.6% of women experienced cardiac complications. Maternal death was reported in 8.69% of 
cases. Four cases were CHD complicated by pulmonary hypertension, which leads to Eisenmenger 
syndrome. Two other cases were AHD complicated by Peripartum Cardiomyopathies. Although 
statistically insignificant, complications are more common in the AHD group than CHD. 
Conclusion: Cardiac disease prevalence in pregnancy is considered high, with CHD as the most 
common case, which significantly differs from other developing countries. 
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Introduction 
Currently, the presence of heart disease among pregnant women is more common. In western 
countries, the prevalence increases from about 0.2 - 0.4% to 1 - 4% during the last few years1,2. 
However, data on Asia are varied and limited, ranging from 0.3 – 5.2%, including Indonesia3–6.  
The burden caused by heart disease in pregnancy is enormous. Heart disease is the leading 
cause of maternal mortality in developed countries. It starts to emerge in developing ones as the 
number of cardiac diseases in low and middle-income countries increases7. The significant 
difference in pregnancy with heart disease between developed and developing countries lies in 
access to prenatal care8. While it is easier to obtain in developed countries, some developing 
countries still struggle in providing accessible antenatal care9. Some countries, including 
Indonesia, do not give the minimum antenatal care recommended by the 2016 WHO ANC model 
10–12. Thus, the early detection of diseases may not be done, and the characteristics of the conditions 
may also vary.  
Studies show that Rheumatic Heart Disease (RHD) is the most common heart disease 
detected during pregnancy in developing countries8,13. The high prevalence of infection and the 
delay of giving antibiotic prophylaxis for Streptococcal infections is the reason behind its high 
burden8. In contrast, congenital heart disease (CHD) is the leading cause of heart disease in 
pregnancy in developed countries as the advance of treatment, and perioperative care could save 
more babies with congenital anomalies1,14,15. Thus, the number of women of reproductive age 
living with CHD increases. Nevertheless, those figures are not necessarily the same between 
regions in the countries. Studies conducted in Australia and New Zealand among the low-economy 
community shows that RHD is more prevalent despite their high-economy country status16. Thus, 
we suggest that there could be a possibility of an increased number of CHD in developing countries 
in regions where the economy is better than the rest of the country.  
Surabaya is the second-largest city in Indonesia with a fairly advanced technology and 
economy. During 2015-2017, preeclampsia/eclampsia is the leading cause of maternal mortality 
in Surabaya17, inconsistent with Indonesia's general situation in which postpartum hemorrhage is 
the leading cause of death18. Understanding the different conditions Surabaya may have, in this 
study, we aim to examine the causes of heart disease in pregnant women and any difference in 
characteristics with previous studies. The second is to investigate any correlation between heart 
disease type with maternal and child outcomes. We believe that any difference in characteristics 
of pregnancy with heart disease will lead to different approaches in preventing its complication. 
Hence, we hope that our study results will provide new insight into pregnancy with heart disease 
in the context of a developing country.  
 
Design and methods 
This cross-sectional study was conducted in Dr. Soetomo General Academic Hospital 
Surabaya, the largest referral hospital in the eastern part of Indonesia.  The data reported were 
emergency cases admitted to the delivery room from January to December 2019 from the Weekly 
Report of Obstetrics and Gynecology Department, Dr. Soetomo General Academic Hospital. The 
study population was all pregnant women with heart disease either coming alone or referred from 
other clinics and hospitals. Patients who were planned for conservative management were 
excluded. Hence, we included 69 deliveries with heart disease of a total of 1328 emergency 
deliveries. 
The study variables were maternal characteristics, including maternal age, gravidity, number 
of antenatal care visits, gestational age, and referral source which has been taken by random 
sampling technique. The clinical parameter observed was heart disease type. Maternal and 
neonatal outcomes examined were the mode of delivery, cardiac complications, postpartum 
contraception, postpartum maternal outcomes, birth weight, and Apgar score. All data variables 
were extracted and collected using a case report form anonymously. We used SPSS version 20.0 
software to detect the potential association between heart diseases and maternal-neonatal 
outcomes. Some variables are adjusted to fit with the chi-square test. P-values < 0.05 were 
considered to be statistically significant.  
 
Results 
There were 69 pregnant women with heart disease out of a total of 1328 deliveries (5.19 %). 
The average age of pregnant women with heart disease was 29.2 + 6.4 years, with the lowest age 
being 16 years and the highest being 44 years. The average gestational age at delivery was 32.2 + 
7.4 weeks, with the youngest was eight weeks, and the oldest was 40 weeks. Most frequent 
deliveries took place at 37 and 38 weeks, but most of the deliveries were preterm. Other 
characteristics of pregnant women can be seen in table 1.  
Table 2 shows the characteristics of heart diseases. The most common heart pathologies were 
CHD, with Atrial Septal Defect (ASD) and Ventricular Septal Defect (VSD) being the most 
common subtype. AHD only accounts for 46.4% of the lesion, with RHD as the leading cause, 
followed by Hypertensive Heart Disease and Peripartum Cardiomyopathy. 
The most significant delivery method was the elective Caesarean Section (CS) (44.9%). 
Seven mothers were not given contraception after deliveries. Most mothers did not experience 
cardiac complications, but four mothers had multiple cardiac complications. Six maternal death 
were recorded in this study. Of these, four cases were caused by CHD and two AHD. The CHD 
case includes two cases of ASD, one case of VSD, and one case of Tetralogy of Fallot. In 
comparison, those with AHD were Peripartum Cardiomyopathies cases. Five of these deaths 
occurred during postpartum periods. Only one case was reported prior to delivery due to ASD 
complicated by severe pulmonary hypertension, which then falls into Eisenmenger syndrome.  
The most prominent obstetric complication was preterm delivery (34.8%). Spontaneous 
abortion was experienced by nine mothers, leaving only 60 infants alive after deliveries. Most of 
the babies (58.3%) had low birth weight, but 81.7 % of babies had an Apgar score > 7 5 minutes 
postpartum (Table 3). We did not find any significant association between type of heart diseases 
with maternal and neonatal outcomes (Table 4).  
 
Discussion 
This study aimed to examine heart disease characteristics in pregnant women with acquired 
and congenital heart disease in developing countries. Our significant finding is the increasing 
prevalence of congenital heart disease despite developing countries' status, which will be discussed 
later in this study. 
Compared to similar studies in Indonesia among pregnant women, heart disease prevalence 
in this study is considered high6,19. The causes of this phenomenon could be two things. First, the 
high rate of pregnant women with heart disease in Dr. Soetomo General Academic Hospital was 
due to a tertiary hospital's status and top referral hospital in East Indonesia, which received referral 
cases from the surrounding area and eastern part of Indonesia. Recommendations from the 
European Society of Cardiology (ESC) states that pregnant women with high-risk heart disease 
must undergo treatment in a central hospital with the expertise to manage pregnancy with heart 
disease14. Second, this increase was consistent with trends occurring globally. The rise in 
prevalence was due to an increased number of women with congenital heart defects who attain 
reproductive age2.   
Heart disease in pregnancy is a high-risk condition and associated with an increase in 
maternal mortality.  However, these poor outcomes can be limited if early detection and quality 
antenatal care can be provided14,20. The 2016 WHO ANC model recommends ANC contacts at 
least eight times to reduce morbidity and mortality rates and enhance positive pregnancy 
experiences. WHO added three more contacts in the third semester to monitor high-risk pregnancy 
and other asymptomatic complications11. In this study, only half of the pregnant women whose 
number of ANC contacts adhere to WHO recommendation despite the previous finding, which 
correlates ANC and potential risk factors for maternal mortality21. Indonesia still practices the 
previous Focused ANC model recommendations, stating that the number of ANC visits during 
pregnancy should not be less than four22. The difference practice in Indonesia could be the results 
of political, logistic, infrastructural, and resources, which was acknowledged by WHO to be the 
problem of countries in low resource settings11. 
We found that the mean age and parity of pregnant women with heart disease in this study 
were consistent with other developing countries. Our study showed that most cases were in 
reproductive ages and multigravida dominated. A study in Vietnam in 2014 - 2016 showed that 
most pregnant women with cardiac disease were 18 - 44 years8. Another study in Africa reported 
that most pregnant women with cardiac disease were < 24 years old and multigravida23. 
Multigravida cases are mostly found in AHD.  
The most significant finding in this study was the clinical characteristics of heart disease. As 
we observed in this study, CHD, instead of AHD, was the most common disorder among pregnant 
women. This finding is not in-line with other studies within many developing worlds, most of 
which have reported RHD to be the most prevalent form of heart disease in pregnancy3,6,8,19. The 
increased prevalence of CHD in our study could result from an increasing number of successful 
surgical repair on CHD for the last decades, which may have potentially increased the life 
expectancy of women with cardiac diseases. Quality of life increases, and social interactions are 
basically normal in this sub-group of patients, and then pregnancy obviously becomes a relevant 
issue.  Data from one referral hospital in Indonesia showed that surgical procedures in CHD had a 
high success rate with low morbidity and mortality24. Another journal revealed that successful 
Tetralogy of Fallot repair was more than 95 % and positively impacted pregnancy outcome25. 
The number of adults with CHD who reach reproduction age and become pregnant is 
increasing. The risk of developing complications of CHD women during pregnancy varies on the 
type of underlying defects and the presence of comorbidities26. In our study, ASD was the most 
common form of CHD, which lies in line with the literature. Generally, ASD during pregnancy is 
well-tolerated, but hemodynamic changes during pregnancy may increase mortality and morbidity 
risk. Moreover, although both repaired and unrepaired ASD are well-tolerated, the repaired one 
has better pregnancy outcomes27. Among our CHD patients, two maternal mortality had unrepaired 
ASD as their underlying heart disease, which falls into Eisenmenger syndrome. This condition 
could indicate the importance of heart disease screening during pregnancy to detect pulmonary 
arterial hypertension and manage it before the condition worsens.  
The most optimal mode of delivery in women with heart disease is debatable since each 
method has its advantage and disadvantage8,28. In the ESC guidelines, vaginal delivery is generally 
preferred, but CS rates in women with heart disease are usually more remarkable than the average 
population28. In this study, elective and emergency CS is more prevalent in the congenital than 
acquired groups, but there is no statistical difference. In both groups, CS is more prevalent than 
vaginal birth. The high prevalence of cardiac complications in this study could explain this 
condition, with CS aimed to perform a safer delivery method for mothers and babies. 
The puerperium is a golden opportunity to provide various contraceptive choices for women 
to lower an unexpected pregnancy risk. It also provides a window for recovery from a previous 
pregnancy, especially in Peripartum Cardiomyopathy29. Our findings indicate that some women in 
this study did not choose modern contraception methods to prevent unplanned pregnancy. This is 
a concern as it can be detrimental to their health if they have an unplanned pregnancy. Women 
with congenital heart disease should know if their offspring are at increased CHD risk. Thereby 
preconception counseling, family planning, and contraception play an essential role. 
The rates of cardiac complications among women with heart disease in this study are higher 
than in the literature. It showed around 37.7% cardiac complications compared to 16% of other 
study complications30,31. In this study, CHD patients had a higher cardiac complication rate than 
AHD patients. Heart failure was the most cardiac complication recorded, followed by lung edema, 
Eisenmenger syndrome, and arrhythmia, respectively. This study also showed that maternal death 
recorded were higher in the CHD group, although statistically insignificant.   Undiagnosed heart 
disease, delay in management, and unrepaired congenital heart disease could lead to complications 
and worsen maternal outcomes32. Thus, early diagnosis of the newborn's asymptomatic congenital 
heart disease will significantly benefit this condition.  
More than 50% of our patients were experiencing obstetric complications. As reported in 
many studies, preterm delivery was the most common obstetric complication recorded23,33. Many 
studies revealed that preterm delivery on cardiac disease in pregnancy could be explained in two 
ways, spontaneous and indicated preterm delivery. Furthermore, spontaneous is higher than 
indicated preterm delivery34. This present study showed the same result. The spontaneous and 
indicated preterm delivery ratio was approximately 0.4 (10/24 cases). The worsening maternal 
condition was the most common reason for delivery indication. 
CHD is the most frequent underlying maternal heart disease in the Western world. Our study 
showed the same situation that four of our maternal death indicated cardiogenic shock secondary 
to pulmonary hypertension and Eisenmenger syndrome in CHD cases. Pregnant women with 
Eisenmenger syndrome from emerging countries and uncorrected congenital heart disease are 
reported to have a high risk of maternal mortality32. Due to insufficient adaptation of the right 
ventricle to increase cardiac output, pulmonary hypertension is poorly tolerated during pregnancy. 
This condition can be pushed into failure by increased cardiac output and potential intravascular 
volume injections during labor. Shifting of postpartum intravascular volume resulting from 
hemorrhage or diuresis is poorly tolerated. Most of our maternal death reported was on the 
peripartum period, a period known as the most significant risk, and most deaths occur between 2 
and 9 days postpartum. Pre-pregnancy evaluation in women with these conditions may influence 
pre-pregnancy advice and management, while current guidelines still advise against pregnancy in 
women with pulmonary hypertension because of high maternal mortality and morbidity rates. This 
is a big problem in our setting because of some delay in heart disease detection and inadequate 
antenatal visit6. Good antenatal care management, early detection of cardiac disease in pregnancy, 
early referral to specialist centers where appropriate, and multidisciplinary expertise should be 
involved in the pregnancy management system. 
We acknowledged that the short data range due to the cross-sectional study was our study's 
limitation. There was no information regarding the time of heart disease diagnosis; hence, it was 
no data about the time of onset of heart disease. In this regard, data from this study also did not 
provide information on whether pregnant women with a history of heart disease had previously 
received counseling about the risk of getting pregnant with heart disease. To our knowledge, this 
is the first epidemiological study that reveals CHD as the leading cause of cardiac disease in 
pregnancy in a developing country. Therefore, further research should be considered. 
 
Conclusion 
Cardiac disease prevalence in pregnancy is considered high, with CHD as the most common case, 
showing a significant difference compared to other developing countries. Cardiac and maternal 
complications are more common in the AHD group than CHD, and maternal death is more 
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Table 1. Characteristics of pregnant women with heart disease.  
Variables n % 
Age 
< 20 years old 3 4.3 
20 – 34 years old 51 73.9 
> 35 years old 15 21.7 
Gravidity 
Primigravida 25 36.2 
Multigravida 44 63.8 
Gestational age 
< 32 weeks 21 30.4 
32 - < 37 weeks 20 29 
> 37 weeks 28 40.6 
Antenatal care visits   
< 8 times 36 47.8 
> 8 times 33 52.2 
Source of referral   
Outpatient Clinic of Dr. Soetomo 
Hospital 
22 36.2 
Other hospitals 37 53.6 
Othersa 10 1.5 
IUD, intra-uterine device; areferred by family obstetrician and come by herself 
Table 2. Clinical characteristics of heart disease.  
Variable n (%) Subtype n  % 
Type of heart disease 
Congenital heart disease 37 (53.6) TOF 4  5.8 
  ASD 18  26.1 
  VSD 12  17.4 
  PDA 2  2.9 
  Ebstein 1  1.4 
Acquired heart disease 32 (46.4) RHD 20 29.0 
  Hypertensive  6  8.7 
  PPCM 5  7.2 
  Conduction 
problem 
1  1.4 
TOF, tetralogy of Fallot; ASD, atrial septal defect; VSD, ventricular septal defect; PDA, patent ductus arteriosus; RHD, rheumatic heart disease; 






Table 3 Maternal and neonatal outcomes. 
Variables n % 
Mode of delivery   
Elective caesarean section 31  44.9 
Emergency caesarean section 13  18.8 
Vaginal birth 25  36.2 
Postpartum contraception   
Without contraception 7  10.1 
IUD 23 33.3 
Permanent  39 56.5 
Maternal cardiac complications   
Without cardiac complications 43  62.3 
Eisenmenger syndrome 5 7.2 
Lung edema 5  7.2 
Heart failure 6  8.7 
Arrhythmia 5  7.2 
Cardiac arrest 1  1.4 
More than one complication 4 5.8 
Obstetric complications   
Without obstetric complications 19 27.5 
Abortion 9 13.0 
Preterm delivery 24 34.8 
Severe preeclampsia 3 4.3 
Premature rupture of the membrane 3 4.3 
Gestational diabetes mellitus 2 2.9 
Placenta previa 1 1.4 
More than one complications 8 11.6 
Postpartum maternal outcomes   
Alive 63  91.3 
Death 6  8.7 
Birth weight*   
Low birth weight 35 58.3 
Normal weight 25 41.7 
5 Minutes Apgar score*   
> 7 49 81.7 
< 7 11 18.3 
IUD, intra-uterine device; *Only count for 60 neonates. 
  






Mode of delivery    
Caesarean section 19 12 0.375 
Emergency caesarean section  5 8  
Vaginal birth 13 12  
Maternal cardiac complications 11 15 0.143 
Maternal obstetric complications 25 25 0.328 
Maternal death 4 2 0.503 
Birth weight*    
Low birth weight 22 13 0.148 
Normal weight 11 14  
5 Minutes Apgar score*    
> 7 28 21 0.520 
< 7 5 6  
*Only count for 60 neonates 
 
 
 
 
